Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$100.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lereno Bio-Chem Ltd. Updates On Proposed Acquisition Of Bintai Kindenko Private Limited


Sunday, 2 Oct 2011 07:50pm EDT 

Lereno Bio-Chem Ltd. announced that further to the earlier announcement with regards to proposed acquisition of Bintai Kindenko Private Limited, the Board of Directors of the Company announced that the conditions precedent in the Acquisition SPA have not been fulfilled and in the light of the current weak market conditions, the parties have mutually agreed not to extend the Completion Date to beyond September 30, 2011. Accordingly, the Acquisition SPA has lapsed and ceased to have any effect, and none of the parties to the Acquisition SPA shall have any claim against the others. The financial impact of the non-completion of the Proposed Acquisition is that the estimated professional fees of approximately S$1.1 million incurred in connection with the Proposed Acquisition will have to be written off in the profit and loss statement of the Group for the financial year ending 31 March 2012. 

Company Quote

0.0060
-0.0010 -14.29%
21 May 2013